AI assistant
Sending…
BOSTON SCIENTIFIC CORP — Director's Dealing 2022
Mar 3, 2022
29821_dirs_2022-03-03_9531e388-a531-49ea-9949-a6114ce5fcbd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2022-03-02
Reporting Person: Brennan Daniel J. (EVP and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-02 | Common Stock | S | 11029.0000 | $44.0339 | Disposed | 264290.0000 | Direct |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.71 to $44.43, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
More from BOSTON SCIENTIFIC CORP
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 8
Major Shareholding Notification
2026
May 6
Regulatory Filings
2026
May 5
Interim / Quarterly Report
2026
May 1
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 2